21-46136370-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001320412.2(FTCD):c.*84C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00214 in 1,467,494 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0016 ( 1 hom., cov: 30)
Exomes 𝑓: 0.0022 ( 6 hom. )
Consequence
FTCD
NM_001320412.2 3_prime_UTR
NM_001320412.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.11
Genes affected
FTCD (HGNC:3974): (formimidoyltransferase cyclodeaminase) The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 21-46136370-G-T is Benign according to our data. Variant chr21-46136370-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 340405.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_001320412.2 | c.*84C>A | 3_prime_UTR_variant | 15/15 | NP_001307341.1 | |||
FTCD | NM_006657.3 | c.*127C>A | 3_prime_UTR_variant | 15/15 | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000397748 | c.*84C>A | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000380856.1 | ||||
FTCD | ENST00000291670 | c.*127C>A | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000291670.5 | ||||
FTCD | ENST00000460011.6 | n.*197C>A | non_coding_transcript_exon_variant | 5/5 | 1 | ENSP00000507070.1 |
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 241AN: 152174Hom.: 1 Cov.: 30
GnomAD3 genomes
AF:
AC:
241
AN:
152174
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00221 AC: 2905AN: 1315202Hom.: 6 Cov.: 19 AF XY: 0.00213 AC XY: 1393AN XY: 653136
GnomAD4 exome
AF:
AC:
2905
AN:
1315202
Hom.:
Cov.:
19
AF XY:
AC XY:
1393
AN XY:
653136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00158 AC: 241AN: 152292Hom.: 1 Cov.: 30 AF XY: 0.00141 AC XY: 105AN XY: 74460
GnomAD4 genome
AF:
AC:
241
AN:
152292
Hom.:
Cov.:
30
AF XY:
AC XY:
105
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Myosclerosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Collagen 6-related myopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
COL6A2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 07, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at